SCHEMBL24200425

SCHEMBL24200425

Cn1c2ccccc2c2ccnc(-c3ccccc3C=O)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.41
FTO Q9C0B1 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HSP90AA1 P07900 2/20 0.40
IDO1 P14902 2/20 0.40
IMPDH2 P12268 1/20 0.40
GPR3 P46089 1/20 0.39
AHR P35869 1/20 0.38
MCL1 Q07820 3/20 0.38
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
LIMK1 P53667 1/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24200393 0.82 RET (0.40) ALDH1A1LMNAATMTDP1PTPN1
SCHEMBL17122538 0.80 ALKBH5 (0.44) ALKBH5FTOHSP90AA1IDO1GPR3
SCHEMBL14956671 0.80 BCHE (0.48) ALKBH5FTOHSP90AA1IDO1GPR3
SCHEMBL20147219 0.80 AHR (0.42) ALKBH5FTOALDH1A1HSP90AA1IDO1
SCHEMBL27992165 0.79 HSP90AA1 (0.50) ALKBH5FTOALDH1A1HSP90AA1IDO1
SCHEMBL24200436 0.76 KDM4E (0.40) ALDH1A1IMPDH2AHRMCL1LMNA
SCHEMBL18014941 0.76 ALKBH5 (0.49) ALKBH5FTOALDH1A1HSP90AA1IDO1
SCHEMBL12938254 0.73 MCL1 (0.64) ALKBH5FTOHSP90AA1IDO1GPR3
SCHEMBL20158850 0.73 NPC1 (0.33) ALDH1A1TDP1MAPTKDM4EMEN1
SCHEMBL3340225 0.72 ALKBH5 (0.51) ALKBH5FTOALDH1A1HSP90AA1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538529-B1 SELECTIVE INHIBITORS OF GENOTOXIC STRESS-INDUCED IKK/NF-KB PATHWAYS MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT (DE) 2022-01-19 EP disclosed